DFDA

Ceftriaxone

Treatment for Meningitis

Typical Dosage: 2g IV every 12-24 hours for adults

Effectiveness
90%
Safety Score
70%
Clinical Trials
5
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
2g IV every 12-24 hours for adults
Time to Effect
immediate
Treatment Duration
7-14 days
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$750
Monitoring:$750
Side Effect Mgmt:$500
Total Annual:$2,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
Outcome-Based Costs
Cost per Responder
$2,222
Cost per Remission
$2,353
Ceftriaxone Outcomes

for Meningitis

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+85%
Common Side Effects
Diarrhea
+8%
Rash
+2.5%
Eosinophilia
+6%

Sources:

nih.gov
nih.gov
mathewsopenaccess.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Ceftriaxone in Meningitis

Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance

NCT04771884RECRUITING
View Study
300 participants
OBSERVATIONAL
Chongqing, China
Started: Oct 1, 2020
Completed Clinical Trials
2 completed trials for Ceftriaxone in Meningitis

Pharmacological Study of High Doses of Ceftriaxone in Meningitidis

NCT01745679COMPLETEDPHASE4
View Study
198 participants
INTERVENTIONAL
Tours, France +6 more
Started: Dec 1, 2012

Infant Severe Sepsis and Bacterial Meningitis in Malawi

NCT01247909COMPLETEDPHASE4
View Study
351 participants
INTERVENTIONAL
Private Bag 360 Blantyre, Malawi
Started: Apr 1, 2010